Stock Picking with Fexingo: Individual Equities, Research, and Building a Concentrated Portfolio

In this episode, Lucas and Luna unpack the hidden implications of corporate America's $2.4 trillion cash hoard — cash that now earns next to nothing as the Federal Reserve holds rates steady. They examine why companies like Apple and Berkshire Hathaway keep piling up cash despite zero interest income, and what this means for stock pickers looking for disciplined capital allocation. With the S&P 500 at 7,415 and yields on short-term Treasuries below 2%, the hosts argue that a growing cash pile can signal either prudence or complacency. They walk through specific examples, including Apple's $62 billion cash position and Berkshire's record $325 billion reserve, and debate whether this cash is a safety buffer or a drag on returns. The conversation ends with a practical framework for evaluating cash-heavy stocks in a concentrated portfolio. This episode is for investors who want to look beyond headline earnings and understand what companies are really doing with their money.

#CorporateCash #Apple #BerkshireHathaway #FederalReserve #CashManagement #CapitalAllocation #StockPicking #ValueInvesting #S&P500 #InterestRates #TreasuryYields #FinancialDiscipline #CashDrag #ConcentratedPortfolio #Finance #Investing #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna examine how the recent megacap tech selloff is creating opportunities for value investors. With NVIDIA down 7.7% in five days and Apple falling 4.5%, they discuss how a concentrated portfolio might benefit from rotating into undervalued sectors like energy and financials. They reference Berkshire Hathaway's 2% gain as a signal of shifting sentiment, and debate whether the old playbook of buying the dip in tech still works. Specific numbers and concrete examples anchor the conversation, including a look at ExxonMobil's 1.4% decline and what it means for dividend-focused investors. The episode is grounded in the market reality of late June 2026.

#MegacapSelloff #ValueInvesting #ConcentratedPortfolio #NVIDIA #Apple #BerkshireHathaway #EnergyStocks #Financials #DividendInvesting #StockPicking #MarketRotation #TechSelloff #ActiveInvesting #Finance #Investing #FexingoBusiness #BusinessPodcast #MarketAnalysis

Keep every episode free: buymeacoffee.com/fexingo

With the Nasdaq down 3.3% in the last five days and NVIDIA falling 7.7%, Lucas and Luna explore why energy stocks like ExxonMobil and Chevron are becoming a surprising anchor for concentrated portfolios. They discuss the dividend yield gap between energy and tech, the impact of AI-driven electricity demand on oil and gas producers, and how the S&P 500's energy weighting has doubled since 2020. The hosts also share how to size an energy position to protect against megacap drawdowns without sacrificing upside. A practical episode for stock pickers navigating the June 2026 rotation.

#EnergyStocks #StockPicking #ConcentratedPortfolio #MegacapTech #NVIDIA #ExxonMobil #Chevron #DividendYield #AIRotation #NasdaqSelloff #PortfolioHedge #ValueInvesting #ActiveManagement #S&P500 #June2026 #Finance #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

This week, SpaceX was fast-tracked into the Nasdaq-100, triggering massive ETF buying demand. Lucas and Luna break down what this means for index funds, active managers, and the growing tension between passive inflows and valuation discipline. They examine the mechanics of forced buying, the precedent set by Tesla's inclusion, and how stock pickers can exploit index rebalancing. Along the way, they touch on the S&P 500's record high of 7,354 and the Russell 2000's modest gains, connecting the dots between megacap concentration and the active opportunity set. A focused, numbers-driven conversation for investors who want to understand the market's plumbing.

#SpaceX #Nasdaq100 #IndexInvesting #PassiveVsActive #StockPicking #ETF #Rebalancing #MarketStructure #Megacap #ElonMusk #FexingoBusiness #BusinessPodcast #Finance #Investing #CapitalMarkets #InstitutionalInvesting #IndexFunds #ActiveManagement

Keep every episode free: buymeacoffee.com/fexingo

SpaceX is joining the Nasdaq-100 in a fast-tracked process starting July 2026, triggering massive ETF buying from funds that track the index. Lucas and Luna break down the mechanics of index inclusion, the estimated $12 billion in forced buying from passive funds, and what it means for active stock pickers. They discuss how the inclusion could boost SpaceX's stock price by 5-8% in the first week, why the fast-track is unusual (SpaceX has only been public for 18 months), and what it signals about the changing nature of megacap growth. They also examine the broader implications for the index — the Nasdaq-100 now has a higher concentration in the top five names than ever before, and SpaceX's inclusion accelerates that trend. For active investors, the key question is whether to front-run the forced buying or wait for the inevitable post-inclusion dip. Lucas shares a specific play: buying SpaceX before the rebalance date and selling after the ETF flows settle. Luna pushes back on the risks of timing such a crowded trade. The episode closes with a practical takeaway for anyone managing a concentrated portfolio.

#SpaceX #Nasdaq100 #IndexInclusion #PassiveInvesting #ActiveManagement #ForceBuying #ETFFlows #Rebalancing #ConcentratedPortfolio #StockPicking #MegacapGrowth #MarketStructure #LucasAndLuna #FexingoBusiness #BusinessPodcast #FinancePodcast #InvestingStrategy #June2026

Keep every episode free: buymeacoffee.com/fexingo

In this episode of Stock Picking with Fexingo, Lucas and Luna explore the resurgence of net-net stocks — a deep-value strategy popularized by Benjamin Graham that targets companies trading below net current asset value. With the S&P 500 at 7,354 and retail investors chasing momentum, net-nets offer a contrarian alternative. Lucas breaks down how a small industrial company, Electro-Scientific Industries, fits the net-net criteria and why this approach works in a frothy market. Luna questions the risks of value traps and liquidation scenarios. The hosts discuss how to screen for net-nets today, the role of activist investors, and what the strategy signals about market breadth. Tune in for a practical guide to uncovering hidden value in a market that many call overvalued.

#NetNetStocks #DeepValue #BenjaminGraham #ValueInvesting #StockPicking #Contrarian #ElectroScientificIndustries #ESIO #S&P500 #MarketBreadth #ActivistInvesting #ValueTrap #BalanceSheet #FexingoBusiness #BusinessPodcast #Finance #Investing #SmallCap

Keep every episode free: buymeacoffee.com/fexingo

With the S&P 500 at 7,373 and the Nasdaq down nearly 3% in a week, Lucas and Luna debate the case for concentrated stock picking. Lucas walks through how Berkshire Hathaway and Nvidia exemplify the trade-off between deep conviction and diversification. Luna questions whether the typical retail investor should hold just 10-15 stocks. They cite Jeremy Grantham's warning about the most expensive market in American history, and look at why Apple and Nvidia have dropped 6-7% in five days while Berkshire gained. A practical conversation about position sizing, risk, and when to ignore the index.

#ConcentratedPortfolio #StockPicking #BerkshireHathaway #Nvidia #JeremyGrantham #MarketValuation #Diversification #RiskManagement #S&P500 #Nasdaq #ActiveInvesting #PortfolioConstruction #PositionSizing #Finance #Investing #FexingoBusiness #BusinessPodcast #June2026

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna examine the recent surge in dividend-focused equity ETFs, which has pushed inflows to the highest level in three years even as the S&P 500 yield hits a 25-year low. They explore what this hunt for yield says about investor sentiment and why buying high-dividend stocks today may signal a defensive posture that could backfire. The episode digs into one specific case: the pitfalls of chasing Pfizer's 8 percent dividend yield after the stock dropped 6 percent in the last five days alone. Lucas and Luna discuss how dividend traps form, what to look for in payout sustainability, and why a concentrated portfolio built on total return often beats a yield-chasing strategy over time.

#DividendStocks #YieldChasing #Pfizer #StockPicking #DividendTraps #EquityETFs #BondETF #S&P500Yield #DefensivePositioning #IncomeInvesting #TotalReturn #PortfolioStrategy #PayoutRatio #Finance #FexingoBusiness #BusinessPodcast #StockResearch #ConcentratedPortfolio

Keep every episode free: buymeacoffee.com/fexingo

The Nasdaq just had its worst week in months, with Apple, Microsoft, and NVIDIA each down over 7 percent in five days. Lucas and Luna unpack why this rotation out of megacap tech is exactly the kind of environment where concentrated stock picking outperforms. They zero in on two specific numbers: the S&P 500's top-ten-concentration at 34 percent and the fact that the equal-weight S&P 500 is actually up. Lucas walks through how he'd approach building a portfolio today — favoring mid-caps and value stocks with real cash flows — and why he's watching companies like JPMorgan and Berkshire Hathaway as potential anchors. Luna pushes back on timing the rotation, and they land on a framework for stock pickers that doesn't depend on calling the macro right.

#StockPicking #ActiveInvesting #MegacapSelloff #Nasdaq #Apple #Microsoft #NVIDIA #JPMorgan #BerkshireHathaway #ValueInvesting #MidCaps #ConcentratedPortfolio #MarketRotation #S&P500 #CashFlows #Finance #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Pfizer's stock has fallen 7.3% in five days and the dividend yield is over 10%. Lucas and Luna examine how the pharma giant's post-Covid revenue collapse has turned what looked like a stable income stock into a high-risk value trap. They walk through the numbers: the dividend payout ratio, the patent cliff, and the pipeline risks. Plus, they contrast Pfizer with JPMorgan's $50 billion buyback announced this week, asking which approach signals better capital discipline. A sharp case study in why yield alone is never the story.

#Pfizer #DividendStocks #ValueTrap #PharmaStocks #StockPicking #ActiveInvesting #Finance #Business #FexingoBusiness #BusinessPodcast #DividendYield #PatentCliff #CapitalAllocation #StressTest #Buyback #JPMorgan #PFE #IncomeInvesting

Keep every episode free: buymeacoffee.com/fexingo